enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Multiple myeloma - Wikipedia

   en.wikipedia.org/wiki/Multiple_myeloma

   MGUS is a relatively stable condition afflicting 3% of people aged 50 and 5% of people aged 70; it progresses to multiple myeloma at a rate of 0.5–1% cases per year; smoldering multiple myeloma does so at a rate of 10% per year for the first 5 years, but then falls off sharply to 3% per year for the next 5 years and thereafter to 1% per year.

3. Myelodysplastic syndrome - Wikipedia

   en.wikipedia.org/wiki/Myelodysplastic_syndrome

   Low risk MDS (which is associated with favorable genetic variants, decreased myeloblastic cells [less than 5% blasts], less severe anemia, thrombocytopenia, or neutropenia or lower International Prognostic Scoring System scores) is associated with a life expectancy of 3–10 years. Whereas high risk MDS is associated with a life expectancy of ...

4. Wikipedia : Manual of Style/Pronunciation

   en.wikipedia.org/.../Pronunciation

   Normally, pronunciation is given only for the subject of the article in its lead section. For non-English words and names, use the pronunciation key for the appropriate language. If a common English rendering of the non-English name exists (Venice, Nikita Khrushchev), its pronunciation, if necessary, should be indicated before the non-English one.

5. What is multiple myeloma? House Majority Leader Steve ... - AOL

   www.aol.com/multiple-myeloma-house-majority...

   No. 2 House Republican Steve Scalise announced his diagnosis with multiple myeloma Tuesday. What is this rare blood cancer?

6. Myelomalacia - Wikipedia

   en.wikipedia.org/wiki/Myelomalacia

   Myelomalacia is a pathological term referring to the softening of the spinal cord. [1] Possible causes of myelomalacia include cervical myelopathy, hemorrhagic infarction, or acute injury, such as that caused by intervertebral disc extrusion.

7. Plasma cell leukemia - Wikipedia

   en.wikipedia.org/wiki/Plasma_cell_leukemia

   Secondary PCL (sPCL) is diagnosed in 1-4% of patients known to have had multiple myeloma for a median time of ~21 months. It is the terminal phase of these patients' myeloma disease. sPCL patients typically are highly symptomatic due to extensive disease with malignant plasma cell infiltrations in, and failures of, not only the bone marrow but also other organs.